Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	json	split
Since AP - 1 and NF - kappa B are key elements in controlling interleukin - 8 ( IL - 8) transcription, human fibroblasts were treated with alpha - MSH and IL - 1 beta for 24 hours, and cytokine levels in the supernatants were measured by ELISA.	AP - 1,6,12,Gene_or_gene_product	NF - kappa B,17,29,Gene_or_gene_product	interleukin - 8,62,77,Gene_or_gene_product	IL - 8,80,86,Gene_or_gene_product	alpha - MSH,139,150,Gene_or_gene_product	IL - 1 beta,155,166,Gene_or_gene_product	"[{""token"": ""AP - 1"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 17, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - MSH"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1 beta"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"	train
METHODS: Using flow cytometry we evaluated 18 human lung cancer cell lines for the expression of different surface markers on lung cancers suggested to be possible prognostic parameters, including epidermal growth factor receptor ( EGFR), intercellular adhesion molecule 1 ( ICAM - 1), Fas and CD40.	epidermal growth factor receptor,197,229,Gene_or_gene_product	EGFR,232,236,Gene_or_gene_product	intercellular adhesion molecule 1,239,272,Gene_or_gene_product	ICAM - 1,275,283,Gene_or_gene_product	Fas,286,289,Gene_or_gene_product	CD40,294,298,Gene_or_gene_product	"[{""token"": ""epidermal growth factor receptor"", ""start_span"": 197, ""end_span"": 229, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 232, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 239, ""end_span"": 272, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 275, ""end_span"": 283, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 286, ""end_span"": 289, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD40"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}]"	train
The therapeutic options available in this regard include measures that: down - regulate serum free IGF - I; suppress the synthesis of mevalonic acid and / or certain derivatives thereof; modulate arachidonate metabolism by inhibiting 5 - lipoxygenase, 12 - lipoxygenase, or COX - 2; antagonize the activation of AP - 1 transcription factors; promote the activation of PPAR - gamma transcription factors; and that suppress angiogenesis by additional mechanisms.	IGF - I,99,106,Gene_or_gene_product	5 - lipoxygenase,234,250,Gene_or_gene_product	12 - lipoxygenase,252,269,Gene_or_gene_product	COX - 2,274,281,Gene_or_gene_product	AP - 1,312,318,Gene_or_gene_product	PPAR - gamma,368,380,Gene_or_gene_product	"[{""token"": ""IGF - I"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""5 - lipoxygenase"", ""start_span"": 234, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""12 - lipoxygenase"", ""start_span"": 252, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 274, ""end_span"": 281, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 312, ""end_span"": 318, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPAR - gamma"", ""start_span"": 368, ""end_span"": 380, ""type"": ""Gene_or_gene_product""}]"	train
A specific histone deacetylase ( HDAc) inhibitor, trichostatin A ( TSA), alleviates Evi - 1 - mediated repression of TGF - beta signaling, suggesting that HDAc is involved in transcriptional repression by Evi - 1.	histone deacetylase,11,30,Gene_or_gene_product	HDAc,33,37,Gene_or_gene_product	Evi - 1,84,91,Gene_or_gene_product	TGF - beta,117,127,Gene_or_gene_product	HDAc,155,159,Gene_or_gene_product	Evi - 1,205,212,Gene_or_gene_product	"[{""token"": ""histone deacetylase"", ""start_span"": 11, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAc"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 117, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAc"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}]"	train
Cyclin - dependent kinase - 2 activity, p107 and cyclin A levels, and retinoblastoma protein phosphorylation are markedly reduced in response to the addition of exogenous SPARC and / or peptides derived from specific domains of SPARC.	Cyclin - dependent kinase - 2,0,29,Gene_or_gene_product	p107,40,44,Gene_or_gene_product	cyclin A,49,57,Gene_or_gene_product	retinoblastoma protein,70,92,Gene_or_gene_product	SPARC,171,176,Gene_or_gene_product	SPARC,228,233,Gene_or_gene_product	"[{""token"": ""Cyclin - dependent kinase - 2"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""p107"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin A"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinoblastoma protein"", ""start_span"": 70, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 228, ""end_span"": 233, ""type"": ""Gene_or_gene_product""}]"	train
Treatment of REF or REF expressing full - length T antigen, an N - terminal segment, or T251 - 708 resulted in increased expression of the p53 - responsive MDM2 gene; apoptosis occurred through a p53 - dependent pathway, as p53 - null cells expressing these T antigens were resistant to 5 - FU - induced apoptosis.	T antigen,49,58,Gene_or_gene_product	p53,139,142,Gene_or_gene_product	MDM2,156,160,Gene_or_gene_product	p53,196,199,Gene_or_gene_product	p53,224,227,Gene_or_gene_product	T antigens,258,268,Gene_or_gene_product	"[{""token"": ""T antigen"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDM2"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}, {""token"": ""T antigens"", ""start_span"": 258, ""end_span"": 268, ""type"": ""Gene_or_gene_product""}]"	train
Western blotting of p53 and murine double mutant 2 ( Mdm2) together with p53 DNA sequencing analysis indicate that p53 function loss by mutation or overexpression of Mdm2 occurred in all tested oral cancer cells regardless of their etiology.	p53,20,23,Gene_or_gene_product	murine double mutant 2,28,50,Gene_or_gene_product	Mdm2,53,57,Gene_or_gene_product	p53,73,76,Gene_or_gene_product	p53,115,118,Gene_or_gene_product	Mdm2,166,170,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine double mutant 2"", ""start_span"": 28, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mdm2"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mdm2"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	train
Looking for mechanisms linking Brn - 3a to carcinogenesis, we discuss the role of this transcription factor in influencing Bcl - 2 / p53 antagonism and Bcl - 2 / VEGF induction of tumor angiogenesis, concluding this review with a proposal for the oncogenic nature of Brn - 3a.	Brn - 3a,31,39,Gene_or_gene_product	Bcl - 2,123,130,Gene_or_gene_product	p53,133,136,Gene_or_gene_product	Bcl - 2,152,159,Gene_or_gene_product	VEGF,162,166,Gene_or_gene_product	Brn - 3a,267,275,Gene_or_gene_product	"[{""token"": ""Brn - 3a"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""Brn - 3a"", ""start_span"": 267, ""end_span"": 275, ""type"": ""Gene_or_gene_product""}]"	train
Because there is little information on the expression of topo I in colorectal tumors, this study evaluated and characterized topo I protein expression in primary colorectal cancer and lymph node metastases and studied the association between topo I protein expression and clinicopathologic data, p53 status, and proliferating cell nuclear antigen ( PCNA) status.	topo I,57,63,Gene_or_gene_product	topo I,125,131,Gene_or_gene_product	topo I,242,248,Gene_or_gene_product	p53,296,299,Gene_or_gene_product	proliferating cell nuclear antigen,312,346,Gene_or_gene_product	PCNA,349,353,Gene_or_gene_product	"[{""token"": ""topo I"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""topo I"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""topo I"", ""start_span"": 242, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 296, ""end_span"": 299, ""type"": ""Gene_or_gene_product""}, {""token"": ""proliferating cell nuclear antigen"", ""start_span"": 312, ""end_span"": 346, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 349, ""end_span"": 353, ""type"": ""Gene_or_gene_product""}]"	train
Experimental Design: Human umbilical vein and dermal microvascular endothelial cells were infected with replication - deficient adenoviruses encoding survivin ( pAd - Survivin), green fluorescent protein ( pAd - GFP), or a phosphorylation - defective survivin Thr ( 34) - - > Ala ( pAd - T34A) dominant negative mutant.	survivin,150,158,Gene_or_gene_product	pAd - Survivin,161,175,Gene_or_gene_product	green fluorescent protein,178,203,Gene_or_gene_product	pAd - GFP,206,215,Gene_or_gene_product	survivin,251,259,Gene_or_gene_product	pAd - T34A,282,292,Gene_or_gene_product	"[{""token"": ""survivin"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAd - Survivin"", ""start_span"": 161, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""green fluorescent protein"", ""start_span"": 178, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAd - GFP"", ""start_span"": 206, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAd - T34A"", ""start_span"": 282, ""end_span"": 292, ""type"": ""Gene_or_gene_product""}]"	train
We show that ING4 physically interacts with p65 ( RelA) subunit of nuclear factor NF - kappaB, and that ING4 regulates brain tumour angiogenesis through transcriptional repression of NF - kappaB - responsive genes.	ING4,13,17,Gene_or_gene_product	p65,44,47,Gene_or_gene_product	RelA,50,54,Gene_or_gene_product	NF - kappaB,82,93,Gene_or_gene_product	ING4,104,108,Gene_or_gene_product	NF - kappaB,183,194,Gene_or_gene_product	"[{""token"": ""ING4"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""p65"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""RelA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""ING4"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"	train
In this study, to examine hypoxia - specific production of anti - angiogenic therapeutic gene, we constructed 5 copies of HRE ( 5xHRE) of human VEGF linked to soluble Tie2 ( sTie2) driven by minimal SV40 promoter ( 5xHRE / SV40 / sTie2).	VEGF,144,148,Gene_or_gene_product	Tie2,167,171,Gene_or_gene_product	sTie2,174,179,Gene_or_gene_product	SV40,199,203,Gene_or_gene_product	SV40,223,227,Gene_or_gene_product	sTie2,230,235,Gene_or_gene_product	"[{""token"": ""VEGF"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie2"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""sTie2"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 223, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}, {""token"": ""sTie2"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Gene_or_gene_product""}]"	train
In addition to p16 ( INK4A), the INK4A locus encodes a splice variant, termed p12 - - specifically expressed in human pancreas - - and ARF, a protein encoded by an alternative reading frame that acts as a tumor suppressor through the p53 pathway.	p16,15,18,Gene_or_gene_product	INK4A,21,26,Gene_or_gene_product	INK4A,33,38,Gene_or_gene_product	p12,78,81,Gene_or_gene_product	ARF,135,138,Gene_or_gene_product	p53,234,237,Gene_or_gene_product	"[{""token"": ""p16"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""p12"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARF"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"	train
Inhibitors of Akt and P13 - kinase, the upstream activator of Akt, block endothelial cell migration and disrupt paxillin localization to the focal adhesions after stimulation with VEGF and S1P.	Akt,14,17,Gene_or_gene_product	P13 - kinase,22,34,Gene_or_gene_product	Akt,62,65,Gene_or_gene_product	paxillin,112,120,Gene_or_gene_product	VEGF,180,184,Gene_or_gene_product	S1P,189,192,Gene_or_gene_product	"[{""token"": ""Akt"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""P13 - kinase"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""paxillin"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"	train
Inhibition of c - Jun amino - terminal kinase ( JNK) blocked type III collagen expression in LRP - 1 - deficient MEFs, suggesting regulation of JNK activity as a mechanism by which LRP - 1 controls mRNA expression.	c - Jun amino - terminal kinase,14,45,Gene_or_gene_product	JNK,48,51,Gene_or_gene_product	type III collagen,61,78,Gene_or_gene_product	LRP - 1,93,100,Gene_or_gene_product	JNK,144,147,Gene_or_gene_product	LRP - 1,181,188,Gene_or_gene_product	"[{""token"": ""c - Jun amino - terminal kinase"", ""start_span"": 14, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""type III collagen"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}]"	train
PCNSLs with HRK methylation also showed methylation of multiple genes, such as p14ARF, p16INK4a, RB1, p27Kip1 and O6 - MGMT.	HRK,12,15,Gene_or_gene_product	p14ARF,79,85,Gene_or_gene_product	p16INK4a,87,95,Gene_or_gene_product	RB1,97,100,Gene_or_gene_product	p27Kip1,102,109,Gene_or_gene_product	O6 - MGMT,114,123,Gene_or_gene_product	"[{""token"": ""HRK"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""p14ARF"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16INK4a"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""RB1"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27Kip1"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""O6 - MGMT"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	train
Mutant mice lacking both cyclin - dependent kinase ( CDK) inhibitors p18 ( Ink4c) and p27 ( Kip1) develop a tumor spectrum reminiscent of human multiple endocrine neoplasia ( MEN) syndromes.	cyclin - dependent kinase,25,50,Gene_or_gene_product	CDK,53,56,Gene_or_gene_product	p18,69,72,Gene_or_gene_product	Ink4c,75,80,Gene_or_gene_product	p27,86,89,Gene_or_gene_product	Kip1,92,96,Gene_or_gene_product	"[{""token"": ""cyclin - dependent kinase"", ""start_span"": 25, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""p18"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4c"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kip1"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	train
Trib1 and Evi1 were up - regulated due to retroviral insertions, and coexpression of these genes significantly accelerated the onset of Hoxa9 / Meis1 - induced AML, suggesting that Trib1 and Evi1 are the key collaborators.	Trib1,0,5,Gene_or_gene_product	Evi1,10,14,Gene_or_gene_product	Hoxa9,136,141,Gene_or_gene_product	Meis1,144,149,Gene_or_gene_product	Trib1,181,186,Gene_or_gene_product	Evi1,191,195,Gene_or_gene_product	"[{""token"": ""Trib1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi1"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hoxa9"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Meis1"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""Trib1"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}]"	train
The induction of vascular endothelial growth factor ( VEGF) and interleukin - 8 ( IL - 8) is an essential feature of tumor angiogenesis, and the hypoxia - inducible factor - 1 ( HIF - 1) transcription factor is known to be a key regulator of this process.	vascular endothelial growth factor,17,51,Gene_or_gene_product	VEGF,54,58,Gene_or_gene_product	interleukin - 8,64,79,Gene_or_gene_product	IL - 8,82,88,Gene_or_gene_product	hypoxia - inducible factor - 1,145,175,Gene_or_gene_product	HIF - 1,178,185,Gene_or_gene_product	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 17, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 64, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia - inducible factor - 1"", ""start_span"": 145, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore, there is strong evidence suggesting that aberrant activation of Wnt signaling induces mammary tumors from stem / progenitor cells, and that Wnt exerts its oncogenic effects through LRP5 / 6 - mediated activation of beta - catenin and mTOR pathways.	Wnt,77,80,Gene_or_gene_product	Wnt,153,156,Gene_or_gene_product	LRP5,194,198,Gene_or_gene_product	6,201,202,Gene_or_gene_product	beta - catenin,228,242,Gene_or_gene_product	mTOR,247,251,Gene_or_gene_product	"[{""token"": ""Wnt"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wnt"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP5"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""6"", ""start_span"": 201, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 228, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene_or_gene_product""}]"	train
These cells were negative for Hep par - 1, carcinoembryonic antigen, neural cell adhesion molecule, CD34, CD31 and HMB45.	Hep par - 1,30,41,Gene_or_gene_product	carcinoembryonic antigen,43,67,Gene_or_gene_product	neural cell adhesion molecule,69,98,Gene_or_gene_product	CD34,100,104,Gene_or_gene_product	CD31,106,110,Gene_or_gene_product	HMB45,115,120,Gene_or_gene_product	"[{""token"": ""Hep par - 1"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinoembryonic antigen"", ""start_span"": 43, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""neural cell adhesion molecule"", ""start_span"": 69, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD31"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMB45"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"	train
Using a construct containing the VEGF promoter linked to a luciferase reporter, we found that a mutation reducing HIF binding to the VEGF promoter had no significant effect on luciferase production induced by M - CSF stimulation.	VEGF,33,37,Gene_or_gene_product	luciferase,59,69,Gene_or_gene_product	HIF,114,117,Gene_or_gene_product	VEGF,133,137,Gene_or_gene_product	luciferase,176,186,Gene_or_gene_product	M - CSF,209,216,Gene_or_gene_product	"[{""token"": ""VEGF"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 176, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSION: These data delineate an ERK - and Sp1 - dependent mechanism of M - CSF induced VEGF production and demonstrate for the first time the ability of M - CSF to induce angiogenesis via VEGF in vivo.	ERK,36,39,Gene_or_gene_product	Sp1,46,49,Gene_or_gene_product	M - CSF,75,82,Gene_or_gene_product	VEGF,91,95,Gene_or_gene_product	M - CSF,157,164,Gene_or_gene_product	VEGF,192,196,Gene_or_gene_product	"[{""token"": ""ERK"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sp1"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: PCR and chimeric BMP - 2 and BMP - 4 luciferase assays demonstrate that NF - kappaB confers robust and selective activation of BMP - 2 in p65 overexpressing or rhTNF - alpha - stimulated PC cells.	BMP - 2,26,33,Gene_or_gene_product	BMP - 4,38,45,Gene_or_gene_product	NF - kappaB,81,92,Gene_or_gene_product	BMP - 2,136,143,Gene_or_gene_product	p65,147,150,Gene_or_gene_product	rhTNF - alpha,169,182,Gene_or_gene_product	"[{""token"": ""BMP - 2"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 4"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""p65"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""rhTNF - alpha"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore, suppression of NF - kappaB activation decreased the transcript levels and BMP - 2 - induced phosphorylation of Smad1 / 5 / 8, critical downstream targets of BMP - 2 signaling in PC cells.	NF - kappaB,28,39,Gene_or_gene_product	BMP - 2,87,94,Gene_or_gene_product	Smad1,124,129,Gene_or_gene_product	5,132,133,Gene_or_gene_product	8,136,137,Gene_or_gene_product	BMP - 2,170,177,Gene_or_gene_product	"[{""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad1"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 132, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""8"", ""start_span"": 136, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}]"	train
Outcomes measures included transcutaneous blood gas levels, histology, total RNA content and analysis of alpha2 ( I) collagen ( COL - I), type IV collagen ( COL - IV), alpha1 ( V) collagen ( COL - V), and vascular endothelial growth factor ( VEGF) expression using real - time quantitative PCR.	COL - I,128,135,Gene_or_gene_product	type IV collagen,138,154,Gene_or_gene_product	COL - IV,157,165,Gene_or_gene_product	COL - V,191,198,Gene_or_gene_product	vascular endothelial growth factor,205,239,Gene_or_gene_product	VEGF,242,246,Gene_or_gene_product	"[{""token"": ""COL - I"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagen"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""COL - IV"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""COL - V"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 205, ""end_span"": 239, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}]"	train
OBJECTIVES: Strategies to inhibit the VEGF pathway, including antibodies to VEGF, antibodies to the extracellular domain of VEGFR - 1 or VEGFR - 2, decoy receptors for VEGF and tyrosine kinase inhibitors of VEGFRs, are summarized.	VEGF,38,42,Gene_or_gene_product	antibodies to VEGF,62,80,Gene_or_gene_product	antibodies to the extracellular domain of VEGFR - 1,82,133,Gene_or_gene_product	VEGFR - 2,137,146,Gene_or_gene_product	VEGF,168,172,Gene_or_gene_product	VEGFRs,207,213,Gene_or_gene_product	"[{""token"": ""VEGF"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""antibodies to VEGF"", ""start_span"": 62, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""antibodies to the extracellular domain of VEGFR - 1"", ""start_span"": 82, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFRs"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Gene_or_gene_product""}]"	train
Semaphorin 7A ( Sema7A) is a membrane - linked semaphorin that is expressed by human keratinocytes, and we have shown that Sema7A binds to human melanocytes through beta1 - integrins and the Plexin C1 receptor.	Semaphorin 7A,0,13,Gene_or_gene_product	Sema7A,16,22,Gene_or_gene_product	semaphorin,47,57,Gene_or_gene_product	Sema7A,123,129,Gene_or_gene_product	beta1 - integrins,165,182,Gene_or_gene_product	Plexin C1 receptor,191,209,Gene_or_gene_product	"[{""token"": ""Semaphorin 7A"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sema7A"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""semaphorin"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sema7A"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta1 - integrins"", ""start_span"": 165, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""Plexin C1 receptor"", ""start_span"": 191, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	train
Since Akt phosphorylates Chk1 - Ser ( 280), the effect of Erbb2 on phosphatidyl inositol - 3 - kinase ( PI3K) / Akt signaling during UV - induced cell cycle arrest was determined.	Akt,6,9,Gene_or_gene_product	Chk1,25,29,Gene_or_gene_product	Erbb2,58,63,Gene_or_gene_product	phosphatidyl inositol - 3 - kinase,67,101,Gene_or_gene_product	PI3K,104,108,Gene_or_gene_product	Akt,112,115,Gene_or_gene_product	"[{""token"": ""Akt"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""Chk1"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erbb2"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidyl inositol - 3 - kinase"", ""start_span"": 67, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"	train
We have shown that Arf6 and its effector AMAP1 ( DDEF1, DEF1, ASAP1 and centaurin beta4) are abnormally overexpressed in some breast cancers and used for their invasion and metastasis.	Arf6,19,23,Gene_or_gene_product	AMAP1,41,46,Gene_or_gene_product	DDEF1,49,54,Gene_or_gene_product	DEF1,56,60,Gene_or_gene_product	ASAP1,62,67,Gene_or_gene_product	centaurin beta4,72,87,Gene_or_gene_product	"[{""token"": ""Arf6"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""AMAP1"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""DDEF1"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""DEF1"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""ASAP1"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""centaurin beta4"", ""start_span"": 72, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSION: Osteopontin siRNA can inhibit U251 cells invasion via the down - regulation of uPA, MMP - 2 and MMP - 9 levels, and promote apoptosis through induction of Bax expression and inhibition of Bcl 2 level.	Osteopontin,12,23,Gene_or_gene_product	uPA,91,94,Gene_or_gene_product	MMP - 2,96,103,Gene_or_gene_product	MMP - 9,108,115,Gene_or_gene_product	Bax,167,170,Gene_or_gene_product	Bcl 2,200,205,Gene_or_gene_product	"[{""token"": ""Osteopontin"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl 2"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}]"	train
Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2 / Akt / mTOR / S6K1 pathways through modulation of Bcl - 2 and BAD.	VEGFR2,74,80,Gene_or_gene_product	Akt,83,86,Gene_or_gene_product	mTOR,89,93,Gene_or_gene_product	S6K1,96,100,Gene_or_gene_product	Bcl - 2,132,139,Gene_or_gene_product	BAD,144,147,Gene_or_gene_product	"[{""token"": ""VEGFR2"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""S6K1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"	train
Thus, these results together suggest that sunitinib initially exerts its apoptotic effect through the inhibition of VEGFR - 2, which, when followed by reduction of its downstream effectors, including Akt / mTOR / S6K1, may lead to inhibition of the antiapoptotic molecule Bcl - 2 and activation of the proapoptotic molecule BAD in PC12 cells.	VEGFR - 2,116,125,Gene_or_gene_product	Akt,200,203,Gene_or_gene_product	mTOR,206,210,Gene_or_gene_product	S6K1,213,217,Gene_or_gene_product	Bcl - 2,272,279,Gene_or_gene_product	BAD,324,327,Gene_or_gene_product	"[{""token"": ""VEGFR - 2"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}, {""token"": ""S6K1"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 272, ""end_span"": 279, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 324, ""end_span"": 327, ""type"": ""Gene_or_gene_product""}]"	train
IL - 17F ablation decreased IL - 1beta and Cox - 2 expression as well as IL - 17 receptor C ( IL - 17RC) expression, which were increased in tumors from Apc ( Min / +) mice.	IL - 17F,0,8,Gene_or_gene_product	IL - 1beta,28,38,Gene_or_gene_product	Cox - 2,43,50,Gene_or_gene_product	IL - 17 receptor C,73,91,Gene_or_gene_product	IL - 17RC,94,103,Gene_or_gene_product	Apc,153,156,Gene_or_gene_product	"[{""token"": ""IL - 17F"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1beta"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cox - 2"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 17 receptor C"", ""start_span"": 73, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 17RC"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""Apc"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore, rat mammary carcinomas with elevated neu expression ( neu - induced) also had sharply elevated LAR - PTPase expression when compared to rat mammary carcinomas with little or no neu expression ( 7, 12 - dimethylbenzanthracene induced); the level of expression of LAR PTPase was directly correlated with the level of neu expression.	neu,50,53,Gene_or_gene_product	neu,67,70,Gene_or_gene_product	LAR - PTPase,108,120,Gene_or_gene_product	neu,190,193,Gene_or_gene_product	LAR PTPase,275,285,Gene_or_gene_product	neu,328,331,Gene_or_gene_product	"[{""token"": ""neu"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAR - PTPase"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAR PTPase"", ""start_span"": 275, ""end_span"": 285, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 328, ""end_span"": 331, ""type"": ""Gene_or_gene_product""}]"	train
By using immunohistochemistry, Western blot, and real - time PCR the expression patterns of TSP - 1, TSP - 2, CD36, CD47, MMP - 2, and MMP - 9 were investigated in normal rat prostate tissue and five malignant Dunning sublines tissue.	TSP - 1,92,99,Gene_or_gene_product	TSP - 2,101,108,Gene_or_gene_product	CD36,110,114,Gene_or_gene_product	CD47,116,120,Gene_or_gene_product	MMP - 2,122,129,Gene_or_gene_product	MMP - 9,135,142,Gene_or_gene_product	"[{""token"": ""TSP - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 2"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD36"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD47"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"	valid
Additionally, knockdown of p600 reduced transformation of cells expressing both BPV - 1 E6 and E7, as well as E6 alone, suggesting that the ability of E7 to transformed cells is mediated, at least in part, through its ability to bind p600.	p600,27,31,Gene_or_gene_product	E6,88,90,Gene_or_gene_product	E7,95,97,Gene_or_gene_product	E6,110,112,Gene_or_gene_product	E7,151,153,Gene_or_gene_product	p600,234,238,Gene_or_gene_product	"[{""token"": ""p600"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 88, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 151, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""p600"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Gene_or_gene_product""}]"	valid
Induction of gelatinases ( matrix metalloproteinase 2 and 9), the serine protease tissue plasminogen activator and plasmin by DCN transfection in MCE cells leads to extracellular proteolysis and to release of matrix - bound VEGF and activation of angiogenesis.	matrix metalloproteinase 2,27,53,Gene_or_gene_product	9,58,59,Gene_or_gene_product	tissue plasminogen activator,82,110,Gene_or_gene_product	plasmin,115,122,Gene_or_gene_product	DCN,126,129,Gene_or_gene_product	VEGF,224,228,Gene_or_gene_product	"[{""token"": ""matrix metalloproteinase 2"", ""start_span"": 27, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""9"", ""start_span"": 58, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue plasminogen activator"", ""start_span"": 82, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmin"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}]"	valid
"Correlation between D2 - 40 + LVI and menopausal - status, HER2 - status and histological type was not significant, while there was a significant correlation of D2 - 40 and so called "" triple negative "" tumors ( ER / PR and HER2neu - negative)."	D2 - 40,20,27,Gene_or_gene_product	HER2,59,63,Gene_or_gene_product	D2 - 40,161,168,Gene_or_gene_product	ER,212,214,Gene_or_gene_product	PR,217,219,Gene_or_gene_product	HER2neu,224,231,Gene_or_gene_product	"[{""token"": ""D2 - 40"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER2"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2 - 40"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 212, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""PR"", ""start_span"": 217, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER2neu"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}]"	valid
Down syndrome critical region gene 1 ( DSCR - 1) short variant ( DSCR - 1s) is an inhibitor of calcineurin / NFAT signaling encoded by exons 4 - 7 of DSCR1.	Down syndrome critical region gene 1,0,36,Gene_or_gene_product	DSCR - 1,39,47,Gene_or_gene_product	DSCR - 1s,65,74,Gene_or_gene_product	calcineurin,95,106,Gene_or_gene_product	NFAT,109,113,Gene_or_gene_product	DSCR1,150,155,Gene_or_gene_product	"[{""token"": ""Down syndrome critical region gene 1"", ""start_span"": 0, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1s"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""calcineurin"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""NFAT"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR1"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	valid
Here, in order to characterize the role of the promoter that drives DSCR - 1s expression in mediating inducible expression in vivo and to determine the functional relevance of DSCR - 1s in inflammation, we targeted a DNA construct containing 1. 7 kb of the human DSCR1s promoter coupled to the lacZ reporter to the hypoxanthine guanine phosphoribosyl transferase ( Hprt) locus of mice.	DSCR - 1s,68,77,Gene_or_gene_product	DSCR - 1s,176,185,Gene_or_gene_product	DSCR1s,263,269,Gene_or_gene_product	lacZ,294,298,Gene_or_gene_product	hypoxanthine guanine phosphoribosyl transferase,315,362,Gene_or_gene_product	Hprt,365,369,Gene_or_gene_product	"[{""token"": ""DSCR - 1s"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1s"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR1s"", ""start_span"": 263, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}, {""token"": ""lacZ"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxanthine guanine phosphoribosyl transferase"", ""start_span"": 315, ""end_span"": 362, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hprt"", ""start_span"": 365, ""end_span"": 369, ""type"": ""Gene_or_gene_product""}]"	valid
Non - specific PKC inhibitors staurosporine and bisindolylmaleimide II as well as inhibitors specific to conventional PKCs ( Go6976) and PKC - delta ( rottlerin) attenuated NF - kappaB activation in BPDE treated cells to a varying degree indicating a possible link between PKC down - regulation and the attenuation of NF - kappaB activity by TSC phenolic fraction.	PKC,15,18,Gene_or_gene_product	PKCs,118,122,Gene_or_gene_product	PKC - delta,137,148,Gene_or_gene_product	NF - kappaB,173,184,Gene_or_gene_product	PKC,273,276,Gene_or_gene_product	NF - kappaB,318,329,Gene_or_gene_product	"[{""token"": ""PKC"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKCs"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKC - delta"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKC"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 318, ""end_span"": 329, ""type"": ""Gene_or_gene_product""}]"	valid
Ploidy analysis was carried out on 39 EOGCs and immunohistochemistry of CDC4 / FBXW7 and its substrates c - myc, c - jun, Notch and cyclin E was performed on 204 gastric carcinomas using tissue microarrays ( TMAs).	CDC4,72,76,Gene_or_gene_product	FBXW7,79,84,Gene_or_gene_product	c - myc,104,111,Gene_or_gene_product	c - jun,113,120,Gene_or_gene_product	Notch,122,127,Gene_or_gene_product	cyclin E,132,140,Gene_or_gene_product	"[{""token"": ""CDC4"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - jun"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin E"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"	valid
The activated PI3K ( phosphoinositide 3 - kinase) / Akt signalling pathway in LNCaP cells contributes to the phosphorylation of PFKFB2 at Ser466 and Ser483, resulting in the constitutive activation of PFK - 2 ( 6 - phosphofructo - 2 - kinase) activity.	PI3K,14,18,Gene_or_gene_product	phosphoinositide 3 - kinase,21,48,Gene_or_gene_product	Akt,52,55,Gene_or_gene_product	PFKFB2,128,134,Gene_or_gene_product	PFK - 2,201,208,Gene_or_gene_product	6 - phosphofructo - 2 - kinase,211,241,Gene_or_gene_product	"[{""token"": ""PI3K"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoinositide 3 - kinase"", ""start_span"": 21, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""PFKFB2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""PFK - 2"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""6 - phosphofructo - 2 - kinase"", ""start_span"": 211, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"	valid
To characterize the effects of CK1delta on SV40 - induced mammary carcinogenesis, we generated transgenic mice expressing mutant CK1delta under the control of the whey acidic protein ( WAP) gene promoter, and crossed them with SV40 transgenic WAP - T - antigen ( WAP - T) mice.	CK1delta,31,39,Gene_or_gene_product	CK1delta,129,137,Gene_or_gene_product	whey acidic protein,163,182,Gene_or_gene_product	WAP,185,188,Gene_or_gene_product	WAP - T - antigen,243,260,Gene_or_gene_product	WAP - T,263,270,Gene_or_gene_product	"[{""token"": ""CK1delta"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""CK1delta"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""whey acidic protein"", ""start_span"": 163, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP - T - antigen"", ""start_span"": 243, ""end_span"": 260, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP - T"", ""start_span"": 263, ""end_span"": 270, ""type"": ""Gene_or_gene_product""}]"	valid
Focal adhesion kinase ( pp125FAK or FAK) is a protein tyrosine kinase which is associated with intracellular signalling cascades which are initiated when the integrin family of cell adhesion molecules engage extracellular matrix molecules.	Focal adhesion kinase,0,21,Gene_or_gene_product	pp125FAK,24,32,Gene_or_gene_product	FAK,36,39,Gene_or_gene_product	protein tyrosine kinase,46,69,Gene_or_gene_product	integrin,158,166,Gene_or_gene_product	cell adhesion molecules,177,200,Gene_or_gene_product	"[{""token"": ""Focal adhesion kinase"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""pp125FAK"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""FAK"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""protein tyrosine kinase"", ""start_span"": 46, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 158, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell adhesion molecules"", ""start_span"": 177, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}]"	valid
Highly specialized cells, the thyrocytes, express a thyroid - specific set of genes for thyroglobulin ( Tg), thyroperoxidase, and the transcription factors TTF - 1, TTF - 2, and Pax - 8.	thyroglobulin,88,101,Gene_or_gene_product	Tg,104,106,Gene_or_gene_product	thyroperoxidase,109,124,Gene_or_gene_product	TTF - 1,156,163,Gene_or_gene_product	TTF - 2,165,172,Gene_or_gene_product	Pax - 8,178,185,Gene_or_gene_product	"[{""token"": ""thyroglobulin"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tg"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""thyroperoxidase"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 2"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pax - 8"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	test
In contrast, there was no association between the expression of AP - 2alpha or AP - 2beta and the level of ErbB - 3, or between AP - 2alpha and AP - 2gamma double positivity and ErbB - 3 expression.	AP - 2alpha,64,75,Gene_or_gene_product	AP - 2beta,79,89,Gene_or_gene_product	ErbB - 3,107,115,Gene_or_gene_product	AP - 2alpha,128,139,Gene_or_gene_product	AP - 2gamma,144,155,Gene_or_gene_product	ErbB - 3,178,186,Gene_or_gene_product	"[{""token"": ""AP - 2alpha"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2beta"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2alpha"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2gamma"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"	test
Co - expression of NRP1 and ( VEGFR - 2) KDR on the surface of endothelial cells ( EC) enhances VEGF165 binding to KDR and EC chemotaxis in response to VEGF165.	NRP1,19,23,Gene_or_gene_product	VEGFR - 2,30,39,Gene_or_gene_product	KDR,41,44,Gene_or_gene_product	VEGF165,96,103,Gene_or_gene_product	KDR,115,118,Gene_or_gene_product	VEGF165,152,159,Gene_or_gene_product	"[{""token"": ""NRP1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"	test
Inhibition of the endothelial cell autocrine angiotensin system, with either the angiotensin - converting enzyme inhibitor lisinopril or the angiotensin II receptor antagonist sar1, ile8 - angiotensin II, leads to increased endothelial cell migration and urokinase - like plasminogen activator ( u - PA) activity ( Bell, L., and J. A. Madri. 1990. Am. J. Pathol. 137: 7 - 12).	angiotensin,45,56,Gene_or_gene_product	angiotensin - converting enzyme,81,112,Gene_or_gene_product	angiotensin II receptor,141,164,Gene_or_gene_product	sar1,176,180,Gene_or_gene_product	urokinase - like plasminogen activator,255,293,Gene_or_gene_product	u - PA,296,302,Gene_or_gene_product	"[{""token"": ""angiotensin"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin - converting enzyme"", ""start_span"": 81, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin II receptor"", ""start_span"": 141, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""sar1"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}, {""token"": ""urokinase - like plasminogen activator"", ""start_span"": 255, ""end_span"": 293, ""type"": ""Gene_or_gene_product""}, {""token"": ""u - PA"", ""start_span"": 296, ""end_span"": 302, ""type"": ""Gene_or_gene_product""}]"	test
In this study we demonstrate that exposure of primary cultures of cardiac and vascular cells to hypoxia or AdCA5, an adenovirus encoding a constitutively active form of HIF - 1alpha, modulates the expression of genes encoding the angiogenic factors angiopoietin - 1 ( ANGPT1), ANGPT2, placental growth factor, and platelet - derived growth factor - B.	HIF - 1alpha,169,181,Gene_or_gene_product	angiopoietin - 1,249,265,Gene_or_gene_product	ANGPT1,268,274,Gene_or_gene_product	ANGPT2,277,283,Gene_or_gene_product	placental growth factor,285,308,Gene_or_gene_product	platelet - derived growth factor - B,314,350,Gene_or_gene_product	"[{""token"": ""HIF - 1alpha"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiopoietin - 1"", ""start_span"": 249, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANGPT1"", ""start_span"": 268, ""end_span"": 274, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANGPT2"", ""start_span"": 277, ""end_span"": 283, ""type"": ""Gene_or_gene_product""}, {""token"": ""placental growth factor"", ""start_span"": 285, ""end_span"": 308, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet - derived growth factor - B"", ""start_span"": 314, ""end_span"": 350, ""type"": ""Gene_or_gene_product""}]"	test
We demonstrate that a decrease in the amount of circulating ANG II by the angiotensin - converting enzyme ( ACE) inhibitor enalapril or the AT1 receptor antagonist losartan induced a stimulation of in vivo angiogenesis implying an inhibitory function of ANG II through the AT1 receptor.	ANG II,60,66,Gene_or_gene_product	angiotensin - converting enzyme,74,105,Gene_or_gene_product	ACE,108,111,Gene_or_gene_product	AT1 receptor,140,152,Gene_or_gene_product	ANG II,254,260,Gene_or_gene_product	AT1 receptor,273,285,Gene_or_gene_product	"[{""token"": ""ANG II"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin - converting enzyme"", ""start_span"": 74, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""ACE"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""AT1 receptor"", ""start_span"": 140, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANG II"", ""start_span"": 254, ""end_span"": 260, ""type"": ""Gene_or_gene_product""}, {""token"": ""AT1 receptor"", ""start_span"": 273, ""end_span"": 285, ""type"": ""Gene_or_gene_product""}]"	test
Colon cancer overexpresses insulin - like growth factor 1 ( IGF1) and insulin - like growth factor 1 receptor ( IGF1 - R), as compared with normal or adenomatous mucosa, and it has been postulated that colorectal cancer cells depend on the IGF1 / IGF1 - R pathway for their growth and progression.	insulin - like growth factor 1,27,57,Gene_or_gene_product	IGF1,60,64,Gene_or_gene_product	insulin - like growth factor 1 receptor,70,109,Gene_or_gene_product	IGF1 - R,112,120,Gene_or_gene_product	IGF1,240,244,Gene_or_gene_product	IGF1 - R,247,255,Gene_or_gene_product	"[{""token"": ""insulin - like growth factor 1"", ""start_span"": 27, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF1"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin - like growth factor 1 receptor"", ""start_span"": 70, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF1 - R"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF1"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF1 - R"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Gene_or_gene_product""}]"	test
Furthermore, induction of MKP - 1 correlated with the inhibition of extracellular signal - regulated kinase ( ERK1 / 2) and c - Jun N - terminal kinase ( JNK) activity, whereas p38 activity was minimally affected.	MKP - 1,26,33,Gene_or_gene_product	extracellular signal - regulated kinase,68,107,Gene_or_gene_product	ERK1 / 2,110,118,Gene_or_gene_product	c - Jun N - terminal kinase,124,151,Gene_or_gene_product	JNK,154,157,Gene_or_gene_product	p38,177,180,Gene_or_gene_product	"[{""token"": ""MKP - 1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 68, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1 / 2"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Jun N - terminal kinase"", ""start_span"": 124, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"	test
Preventing VEGFR1 function using antibodies or by the removal of VEGFR1 ( +) cells from the bone marrow of wild - type mice abrogates the formation of these pre - metastatic clusters and prevents tumour metastasis, whereas reconstitution with selected Id3 ( inhibitor of differentiation 3) - competent VEGFR1 + cells establishes cluster formation and tumour metastasis in Id3 knockout mice.	VEGFR1,11,17,Gene_or_gene_product	VEGFR1,65,71,Gene_or_gene_product	Id3,252,255,Gene_or_gene_product	inhibitor of differentiation 3,258,288,Gene_or_gene_product	VEGFR1,302,308,Gene_or_gene_product	Id3,372,375,Gene_or_gene_product	"[{""token"": ""VEGFR1"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""Id3"", ""start_span"": 252, ""end_span"": 255, ""type"": ""Gene_or_gene_product""}, {""token"": ""inhibitor of differentiation 3"", ""start_span"": 258, ""end_span"": 288, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 302, ""end_span"": 308, ""type"": ""Gene_or_gene_product""}, {""token"": ""Id3"", ""start_span"": 372, ""end_span"": 375, ""type"": ""Gene_or_gene_product""}]"	test
G ( i) protein, phosphatidylinositol - 3 kinase ( PI3K), p38 mitogen - activated protein kinase ( MAPK), cytosolic phospholipase A ( 2) and urokinase type plasminogen activator ( uPA) are required for LPA - induced cells invasion.	phosphatidylinositol - 3 kinase,16,47,Gene_or_gene_product	PI3K,50,54,Gene_or_gene_product	p38 mitogen - activated protein kinase,57,95,Gene_or_gene_product	MAPK,98,102,Gene_or_gene_product	urokinase type plasminogen activator,140,176,Gene_or_gene_product	uPA,179,182,Gene_or_gene_product	"[{""token"": ""phosphatidylinositol - 3 kinase"", ""start_span"": 16, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 mitogen - activated protein kinase"", ""start_span"": 57, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""urokinase type plasminogen activator"", ""start_span"": 140, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"	test
After SCC transformation, the absence of G45 domain in DeltaG45 cells was associated with deficient extracellular signal - regulated kinase and phosphotidylinositol 3 - kinase ( PI3K) pathway activation, impaired invasion, deficient metalloproteinase activity, and absent tumorgenicity in vivo.	G45,41,44,Gene_or_gene_product	DeltaG45,55,63,Gene_or_gene_product	extracellular signal - regulated kinase,100,139,Gene_or_gene_product	phosphotidylinositol 3 - kinase,144,175,Gene_or_gene_product	PI3K,178,182,Gene_or_gene_product	metalloproteinase,233,250,Gene_or_gene_product	"[{""token"": ""G45"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""DeltaG45"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 100, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphotidylinositol 3 - kinase"", ""start_span"": 144, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""metalloproteinase"", ""start_span"": 233, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}]"	test
We have found out that docetaxel - ATRA combination significantly downregulates survivin ( BIRC5), myeloid cell leukemia - 1 ( MCL - 1) and lymphotoxin beta - receptor ( LTbetaR) genes, which all three have pivotal roles in regulation of apoptosis and cell cycle progression.	survivin,80,88,Gene_or_gene_product	BIRC5,91,96,Gene_or_gene_product	myeloid cell leukemia - 1,99,124,Gene_or_gene_product	MCL - 1,127,134,Gene_or_gene_product	lymphotoxin beta - receptor,140,167,Gene_or_gene_product	LTbetaR,170,177,Gene_or_gene_product	"[{""token"": ""survivin"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""BIRC5"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid cell leukemia - 1"", ""start_span"": 99, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCL - 1"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphotoxin beta - receptor"", ""start_span"": 140, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTbetaR"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}]"	test
Robo1 and Robo4 interact and share molecules such as Slit2, Mena and Vilse, a Cdc42 - GAP.	Robo1,0,5,Gene_or_gene_product	Robo4,10,15,Gene_or_gene_product	Slit2,53,58,Gene_or_gene_product	Mena,60,64,Gene_or_gene_product	Vilse,69,74,Gene_or_gene_product	Cdc42 - GAP,78,89,Gene_or_gene_product	"[{""token"": ""Robo1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo4"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""Slit2"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mena"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""Vilse"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc42 - GAP"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"	test
To verify that P18 acts in the same manner as PEDF, we used immunohistochemistry to measure PEDF targets, vascular endothelial growth factor receptor 2, and CD95 ligand expression in P18 - treated vasculature.	P18,15,18,Gene_or_gene_product	PEDF,46,50,Gene_or_gene_product	PEDF targets,92,104,Gene_or_gene_product	vascular endothelial growth factor receptor 2,106,151,Gene_or_gene_product	CD95 ligand,157,168,Gene_or_gene_product	P18,183,186,Gene_or_gene_product	"[{""token"": ""P18"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF targets"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor receptor 2"", ""start_span"": 106, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD95 ligand"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""P18"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"	test
TSC2 and PTEN are two key inhibitors of the Akt / mammalian target of rapamycin ( mTOR) pathway and the specific inhibition of mTOR with rapamycin or RAD001 inhibited cell proliferation of PET cell lines.	TSC2,0,4,Gene_or_gene_product	PTEN,9,13,Gene_or_gene_product	Akt,44,47,Gene_or_gene_product	mammalian target of rapamycin,50,79,Gene_or_gene_product	mTOR,82,86,Gene_or_gene_product	mTOR,127,131,Gene_or_gene_product	"[{""token"": ""TSC2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammalian target of rapamycin"", ""start_span"": 50, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	test
Ectopic expression of TLX in the U87MG glioma cell line and Ink4a / Arf - deficient mouse astrocytes ( Ink4a / Arf ( - / -) astrocytes) induced cell proliferation with a concomitant increase in cyclin D expression, and accelerated foci formation in soft agar and tumor formation in in vivo transplantation assays.	TLX,22,25,Gene_or_gene_product	Ink4a,60,65,Gene_or_gene_product	Arf,68,71,Gene_or_gene_product	Ink4a,103,108,Gene_or_gene_product	Arf,111,114,Gene_or_gene_product	cyclin D,194,202,Gene_or_gene_product	"[{""token"": ""TLX"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin D"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}]"	test
Because AR - ARD1 interaction facilitated the AR binding to its targeted promoters for gene transcription, we propose that ARD1 functions as a unique AR regulator and forms a positive feedback loop for AR - dependent prostate tumorigenesis.	AR,8,10,Gene_or_gene_product	ARD1,13,17,Gene_or_gene_product	AR,46,48,Gene_or_gene_product	ARD1,123,127,Gene_or_gene_product	AR,150,152,Gene_or_gene_product	AR,202,204,Gene_or_gene_product	"[{""token"": ""AR"", ""start_span"": 8, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARD1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARD1"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 150, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 202, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}]"	test
However, E mu - directed coexpression of cyclin D1 and N - MYC or L - MYC in double transgenic mice reveals a strong cooperative effect between MYC and cyclin D1 provoking the rapid development of clonal pre - B and B - cell lymphomas.	E mu,9,13,Gene_or_gene_product	cyclin D1,41,50,Gene_or_gene_product	N - MYC,55,62,Gene_or_gene_product	L - MYC,66,73,Gene_or_gene_product	MYC,144,147,Gene_or_gene_product	cyclin D1,152,161,Gene_or_gene_product	"[{""token"": ""E mu"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin D1"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - MYC"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""L - MYC"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin D1"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}]"	test
